Literature DB >> 4568460

The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata.

D M Thomson, K Steele, P Alexander.   

Abstract

Antibodies to the tumour-specific transplantation type antigen (TSTA) of a transplanted methylcholanthrene-induced sarcoma (MC-1) in syngeneic rats were studied using the techniques of indirect membrane immunofluorescence and mixed haemadsorption with a (51)Cr-labelled indicator cell. After tumour excision, anti-TSTA antibody was readily measurable in both serum and lymph. In contrast, the tumour-bearing animal had no measurable anti-TSTA antibody in the serum but low titres in the lymph. Consequently, we formed the hypothesis that in the presence of a growing tumour the serum contained antigen-antibody complexes with antigen in excess.To test this hypothesis, tumour-bearing serum was examined for the presence of free antigen and antigen-antibody complexes by 2 different methods. In the first method, tumour-bearing serum was cross-linked with glutaraldehyde and was found to absorb specifically the anti-TSTA antibody, indicating free circulating TSTA. Next, antigen-antibody complexes were split with salt or acid and separated into a low molecular weight (or "antigen") fraction (<100,000) and a high molecular weight (or "antibody") fraction (>100,000). The low M.W. fraction specifically inhibited the anti-TSTA antibody when tested by either membrane immunofluorescence or mixed haemadsorption, indicating the presence of antigen from antigen-antibody complexes in the tumour-bearing circulation. The possible effect on the host's immune response of circulating free tumour antigen and antigen-antibody complexes are discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4568460      PMCID: PMC2008825          DOI: 10.1038/bjc.1973.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

Review 2.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

3.  Detection of cell surface antigens on monolayer cells. II. The application of mixed haemadsorption on a micro scale.

Authors:  T Tachibana; P Worst; E Klein
Journal:  Immunology       Date:  1970-11       Impact factor: 7.397

4.  Demonstration of cellular antigens on sarcoma cells by an indirect 125-I-labeled antibody technique.

Authors:  F H Harder; C F McKhann
Journal:  J Natl Cancer Inst       Date:  1968-02       Impact factor: 13.506

5.  Antibodies to spontaneous and methylcholanthrene-induced tumors in inbred mice.

Authors:  Y H Pilch; R S Riggins
Journal:  Cancer Res       Date:  1966-05       Impact factor: 12.701

6.  Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum.

Authors:  R K Charlton; C M Zmijewski
Journal:  Science       Date:  1970-11-06       Impact factor: 47.728

7.  The immediate effect of antigens on the cell output of a lymph node.

Authors:  J G Hall; B Morris
Journal:  Br J Exp Pathol       Date:  1965-08

8.  Simplified procedure for preparation of specific antibodies to gamma globulins.

Authors:  R G Olsen; J R McCammon; D S Yohn
Journal:  Appl Microbiol       Date:  1970-07

9.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors:  D M Thomson; J Krupey; S O Freedman; P Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

10.  Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.

Authors:  R W Baldwin; C R Barker
Journal:  Br J Cancer       Date:  1967-12       Impact factor: 7.640

View more
  17 in total

1.  Use of the defined antigen substrate spheres system as a model for analysing possible mechanisms of inhibition-blockade of anti-tumour lymphocytotoxicity.

Authors:  N Matthews; T de Kretser; R C Nairn
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Significance of serum factors modifying cellular immune responses to growing tumours.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Br J Cancer Suppl       Date:  1973-08

3.  The role of circulating antigen as an inhibitor of tumour immunity in man.

Authors:  G Currie
Journal:  Br J Cancer Suppl       Date:  1973-08

4.  Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour.

Authors:  P M Comoglio; M Bertini; G Forni
Journal:  Immunology       Date:  1975-08       Impact factor: 7.397

5.  Failure to detect soluble tumor associated antigen by radioimmunoassay in bovine lymphoma.

Authors:  R M Jacobs; V E Valli; B N Wilkie
Journal:  Can J Comp Med       Date:  1981-01

6.  Rat tumour allografts evoke anaphylactic antibody responses.

Authors:  B C Broom; P Alexander
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

7.  Immunological escape mechanism in spontaneously metastasizing mammary tumors.

Authors:  U Kim; A Baumler; C Carruthers; K Bielat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

8.  Changes in host immunity following excision of a murine melanoma.

Authors:  A E Bray; D Keast
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

9.  Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata.

Authors:  D M Thomson; S Eccles; P Alexander
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

10.  Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.

Authors:  D M Thomson; V Sellens; S Eccles; P Alexander
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.